• Mashup Score: 1
    The Capability of ChatGPT in Predicting and Explaining Common Drug-Drug Interactions - 1 year(s) ago

    Background Drug-drug interactions (DDIs) can have serious consequences for patient health and well-being. Patients who are taking multiple medications may be at an increased risk of experiencing adverse events or drug toxicity if they are not aware of potential interactions between their medications. Many times, patients self-prescribe medications without knowing DDI. Objective The objective…

    Source: www.cureus.com
    Categories: Healthcare Professionals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of HealthcareLdr
      HealthcareLdr

      The Capability of #ChatGPT in Predicting and Explaining Common Drug-Drug Interactions https://t.co/5Qzz5ysxTF @cureusinc #MedTech #AI #mHealth #healthcare #HealthTech #HealthIT #HIMSS23 #HIMSS #pharmacology #lifesciences #drugdiscovery #medicine #medications #DigitalHealth https://t.co/aSHUx2Hape

  • Mashup Score: 0
    Doctoral research network to study small molecule-drug conjugates for cancer treatment - 1 year(s) ago

    Doctoral researchers from 11 European institutions and four companies have formed a research network dedicated to developing molecules that stimulate the immune response to tumor cells.The network, “Magicbullet::reloaded,” consists of 15 doctoral researchers from organic and medicinal chemistry, tumor biology and pharmacology. The researchers plan to conduct studies in this network

    Source: www.healio.com
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of HemOncToday
      HemOncToday

      Doctoral research network to study small molecule-drug conjugates for cancer treatment. https://t.co/l0O42EIPVm @unimib @unibielefeld #HemOnc #OncAlert #MedEd #pharmacology #research

  • Mashup Score: 6
    FDA approves new medication for type 2 diabetes - 1 year(s) ago

    TheracosBio, a Massachusetts-based pharmaceutical company, has gained U.S. Food and Drug Administration (FDA) approval for bexagliflozin, an oral sodium-glucose cotransporter 2 (SGLT2) inhibitor designed to improve glycemic control in adults with type 2 diabetes. The newly approved medication, marketed under the name Brenzavvy, is available as 20 mg tablets that patients take once daily. It is…

    Source: Cardiovascular Business
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of CardioBusiness
      CardioBusiness

      FDA approves new medication for type 2 diabetes @MassGeneralNews #cardiology #cardiotwitter #pharmacology #pharma #diabetes https://t.co/06LTmut2pq

  • Mashup Score: 1
    Cholesterol metabolism in the regulation of inflammatory responses - 1 year(s) ago

    The importance of biologically active lipid mediators, such as prostanoids, leukotrienes, and specialized pro-resolving mediators, in the regulation of inflammation is well established. While the relevance of cholesterol in the context of atherosclerosis is also widely accepted, the role of cholesterol and its biosynthetic precursors on inflammatory processes is less comprehensively described. In…

    Source: Frontiers
    Categories: Healthcare Professionals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of DrFerdowsi
      DrFerdowsi

      RT @FrontPharmacol: New Research: Cholesterol metabolism in the regulation of inflammatory responses https://t.co/sn7x2gTSZ3 #pharmacology

  • Mashup Score: 0
    Getting to the Heart of Chemotherapeutic Cardiotoxicity - 1 year(s) ago

    January 16, 2023 — On any given Tuesday, you will find Brian C. Jensen, MD, cardiologist and physician-scientist, tending to patients in his cardio-oncology clinic. His schedule is packed to the brim with cancer patients. But not patients with heart cancer. The largest number of patients he sees are cancer patients who have developed, or are at risk of developing, heart damage in response to…

    Source: DAIC
    Categories: Cardiologists, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of DAICeditor
      DAICeditor

      @DAICeditor @UNCMedCenter Brian C. Jensen, associate professor of #medicine and #pharmacology in the Department of Medicine’s Division of #Cardiology, speaks about his research on #kinase inhibitor #cardiotoxicity: https://t.co/12w9Giag8F

Load More